NWAG
WST icon

Net Worth Advisory Group’s West Pharmaceutical WST Stock Holding History

Net Worth Advisory Group’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$694K Sell
1,933
-198
-9% -$60.5K 0.17% 137
2026
Q1 		$534K Buy
2,131
+356
+20% +$88.6K 0.11% 190
2025
Q4 		$488K Sell
1,775
-312
-15% -$85.3K 0.1% 216
2025
Q3 		$547K Sell
2,087
-1,687
-45% -$410K 0.16% 150
2025
Q2 		$826K Buy
3,774
+922
+32% +$197K 0.18% 106
2025
Q1 		$639K Buy
2,852
+1,004
+54% +$277K 0.2% 109
2024
Q4 		$605K Sell
1,848
-227
-11% -$71.4K 0.18% 134
2024
Q3 		$623K Buy
+2,075
New +$635K 0.18% 149

Other funds holding WST

RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
SIM
Seilern Investment Management London, United Kingdom $794M AUM 6.63% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $77B AUM 50.57% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
MCG
McCollum Christoferson Group Amherst, New York $341M AUM 15.01% 1-Year Est. Return
BZWA
Blue Zone Wealth Advisors Los Angeles, California $573M AUM 22.86% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
AC
Apella Capital West Hartford, Connecticut $7.08B AUM 17.38% 1-Year Est. Return
P
PensionDanmark Copenhagen O, Denmark $12B AUM